Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease, and the currently available techniques for its detection are either invasive or less sensitive. To overcome this limitation, we present here a multiplexed point-of-care test that combines systemic inflammatory respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Digiacomo, Luca, Quagliarini, Erica, Pozzi, Daniela, Coppola, Roberto, Caracciolo, Giulio, Caputo, Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251844/
https://www.ncbi.nlm.nih.gov/pubmed/37296945
http://dx.doi.org/10.3390/cancers15112983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251844/
https://www.ncbi.nlm.nih.gov/pubmed/37296945
http://dx.doi.org/10.3390/cancers15112983

Ejemplares similares